NAUT · Nautilus Biotechnology, Inc. · Proposed Sales
$2.31
-0.02 (-0.65%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$295.50M
Shares
127.37M
Volume · Nov 16
1.75M
Avg daily vol (3M)
5.87M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2024-12-17 | MARY GODWIN | Officer | 38,337 | 2024-12-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-12-09 | MARY GODWIN | Officer | 35,000 | 2024-12-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-12-03 | MARY GODWIN | Officer | 60,000 | 2024-12-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-11-26 | MARY GODWIN | Officer | 60,000 | 2024-11-26 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-11-21 | MARY GODWIN | Officer | 30,000 | 2024-11-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-11-19 | MARY GODWIN | Officer | 30,000 | 2024-11-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-11-12 | MARY GODWIN | Officer | 40,000 | 2024-11-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-11-08 | MARY ELIZABETH GODWIN | Officer | 31,078 | 2024-11-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-11-07 | MARY ELIZABETH GODWIN | Officer | 28,922 | 2024-11-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-09-23 | MARY ELIZABETH GODWIN | Officer | 47,031 | 2024-09-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-09-17 | MARY ELIZABETH GODWIN | Officer | 35,000 | 2024-09-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–11 of 11 filings
Key facts
CIK
1808805
CUSIP
63909J108
13F (30d)
65 filings
54 filers
Visit website
Investor relations